Samphire Neuroscience
Summary
In a significant market movement during February 2024, Samphire Neuroscience was the subject of a vc funding. The transaction achieved a gross valuation of £1,797,999. Leading the round was FIRSTPICK, Russell Buckley, Dr Pamela Walker, CVX Ventures, Afterwork, Ayuh, Seaside, SOSV.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
FIRSTPICK
Lead Investor / Acquirer
Russell Buckley
Lead Investor / Acquirer
Dr Pamela Walker
Lead Investor / Acquirer
CVX Ventures
Lead Investor / Acquirer
Afterwork
Lead Investor / Acquirer
Ayuh
Lead Investor / Acquirer
Seaside
Lead Investor / Acquirer
SOSV
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Pre-Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in